226 related articles for article (PubMed ID: 8640943)
1. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice.
Battalora MS; Conti CJ; Aldaz CM; Slaga TJ; Johnston DA; DiGiovanni J
Carcinogenesis; 1996 May; 17(5):955-60. PubMed ID: 8640943
[TBL] [Abstract][Full Text] [Related]
2. Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice.
DiGiovanni J; Walker SE; Aldaz CM; Slaga TJ; Conti CJ
Carcinogenesis; 1993 Sep; 14(9):1831-6. PubMed ID: 8403206
[TBL] [Abstract][Full Text] [Related]
3. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
Kruszewski FH; Conti CJ; DiGiovanni J
Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
[TBL] [Abstract][Full Text] [Related]
4. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
5. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
6. Skin tumorigenesis by initiators and promoters of different chemical structures in lines of mice selectively bred for resistance (Car-r) or susceptibility (Car-s) to two-stage skin carcinogenesis.
Saran A; Pazzaglia S; Rebessi S; Bouthillier Y; Pioli C; Covelli V; Mouton D; Doria G; Biozzi G
Int J Cancer; 1999 Oct; 83(3):335-40. PubMed ID: 10495425
[TBL] [Abstract][Full Text] [Related]
7. Histologic alterations produced by chrysarobin (1,8-dihydroxy-3-methyl-9-anthrone) in SENCAR mouse skin: relationship to skin tumor promoting activity.
Kruszewski FH; Naito M; Naito Y; DiGiovanni J
J Invest Dermatol; 1989 Jan; 92(1):64-71. PubMed ID: 2462598
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of mouse skin tumor promotion by chrysarobin.
DiGiovanni J; Decina PC; Prichett WP; Cantor J; Aalfs KK; Coombs MM
Cancer Res; 1985 Jun; 45(6):2584-9. PubMed ID: 3986797
[TBL] [Abstract][Full Text] [Related]
9. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation.
Ewing MW; Crysup SE; Phillips JL; Slaga TJ; DiGiovanni J
Carcinogenesis; 1988 Mar; 9(3):405-10. PubMed ID: 3125993
[TBL] [Abstract][Full Text] [Related]
11. Modulation of chrysarobin skin tumor promotion.
DiGiovanni J; Kruszewski FH; Chenicek KJ
Carcinogenesis; 1988 Aug; 9(8):1445-50. PubMed ID: 3135955
[TBL] [Abstract][Full Text] [Related]
12. Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols.
Katiyar SK; Mohan RR; Agarwal R; Mukhtar H
Carcinogenesis; 1997 Mar; 18(3):497-502. PubMed ID: 9067548
[TBL] [Abstract][Full Text] [Related]
13. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
14. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
Ewing MW; Conti CJ; Phillips JL; Slaga TJ; DiGiovanni J
J Natl Cancer Inst; 1989 May; 81(9):676-82. PubMed ID: 2496233
[TBL] [Abstract][Full Text] [Related]
15. Tumor promoting activity of 1,8-dihydroxy-3-methyl-9-anthrone (chrysarobin) in female SENCAR mice.
DiGiovanni J; Boutwell RK
Carcinogenesis; 1983; 4(3):281-4. PubMed ID: 6831635
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E is a complete tumor promoter in mouse skin.
Mitchel RE; McCann R
Carcinogenesis; 1993 Apr; 14(4):659-62. PubMed ID: 8472330
[TBL] [Abstract][Full Text] [Related]
17. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
[TBL] [Abstract][Full Text] [Related]
18. Promoter independence as a feature of most skin papillomas in SENCAR mice.
Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J
Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044
[TBL] [Abstract][Full Text] [Related]
19. Induction of papillomas with a high probability of conversion to malignancy.
Hennings H; Shores R; Mitchell P; Spangler EF; Yuspa SH
Carcinogenesis; 1985 Nov; 6(11):1607-10. PubMed ID: 2414025
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a common genetic pathway controlling susceptibility to mouse skin tumor promotion by diverse classes of promoting agents.
DiGiovanni J; Walker SC; Beltran L; Naito M; Eastin WC
Cancer Res; 1991 Mar; 51(5):1398-405. PubMed ID: 1900038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
